NYSE:EHCEncompass Health Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Encompass Health Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $62.06 -0.89 (-1.41 %) (As of 07/8/2020 04:00 PM ET) Add Compare Share Today's Range$61.33Now: $62.06▼$62.8950-Day Range$59.31MA: $67.89▼$74.9752-Week Range$48.01Now: $62.06▼$83.30Volume580,300 shsAverage Volume814,371 shsMarket Capitalization$6.17 billionP/E Ratio17.99Dividend Yield1.80%Beta0.88 ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendEarningsHeadlinesOptions ChainSocial Media Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of February 21, 2019, Encompass Health Corporation operated 130 hospitals, and 278 home health and hospice agencies in 36 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingEncompass Health has received a consensus rating of Buy. The company's average rating score is 2.90, and is based on 9 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $91.78, Encompass Health has a potential upside of 47.9% from its current price of $62.06.Amount of Analyst CoverageEncompass Health has only been the subject of 2 research reports in the past 90 days. Previous Next 2.7 Community Rank Outperform VotesEncompass Health has received 174 “outperform” votes. (Add your “outperform” vote.)Underperform VotesEncompass Health has received 147 “underperform” votes. (Add your “underperform” vote.)Community SentimentEncompass Health has received 54.21% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Encompass Health and other stocks. Vote “Outperform” if you believe EHC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EHC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 3.3 Dividend Strength Dividend YieldEncompass Health pays a meaningful dividend of 1.80%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthEncompass Health has been increasing its dividend for 6 years.Dividend CoverageThe dividend payout ratio of Encompass Health is 28.64%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Encompass Health will have a dividend payout ratio of 27.59% next year. This indicates that Encompass Health will be able to sustain or increase its dividend. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Encompass Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.80% of the stock of Encompass Health is held by insiders.Percentage Held by Institutions92.65% of the stock of Encompass Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Encompass Health are expected to grow by 32.25% in the coming year, from $3.07 to $4.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Encompass Health is 17.99, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.83.Price to Earnings Ratio vs. SectorThe P/E ratio of Encompass Health is 17.99, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.52.Price to Earnings Growth RatioEncompass Health has a PEG Ratio of 7.25. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioEncompass Health has a P/B Ratio of 3.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™2.47 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Hospitals Sub-IndustryN/A SectorMedical Current SymbolNYSE:EHC Previous Symbol CUSIPN/A CIKN/A Webwww.encompasshealth.com Phone205-967-7116Debt Debt-to-Equity Ratio1.98 Current Ratio1.34 Quick Ratio1.34Price-To-Earnings Trailing P/E Ratio17.99 Forward P/E Ratio20.21 P/E Growth7.25 Sales & Book Value Annual Sales$4.61 billion Price / Sales1.34 Cash Flow$6.13 per share Price / Cash Flow10.12 Book Value$17.17 per share Price / Book3.61Profitability EPS (Most Recent Fiscal Year)$3.91 Net Income$358.70 million Net Margins7.36% Return on Equity22.00% Return on Assets6.08%Miscellaneous Employees31,570 Outstanding Shares99,405,000Market Cap$6.17 billion Next Earnings DateN/A OptionableOptionable EHC Rates by TradingView Receive EHC News and Ratings via Email Sign-up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter. Encompass Health (NYSE:EHC) Frequently Asked Questions How has Encompass Health's stock been impacted by COVID-19 (Coronavirus)? Encompass Health's stock was trading at $63.85 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, EHC shares have decreased by 2.8% and is now trading at $62.06. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Encompass Health? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Encompass Health. How were Encompass Health's earnings last quarter? Encompass Health Corp (NYSE:EHC) announced its earnings results on Tuesday, April, 28th. The company reported $0.87 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.87. The firm earned $1.18 billion during the quarter, compared to analysts' expectations of $1.20 billion. Encompass Health had a return on equity of 22.00% and a net margin of 7.36%. View Encompass Health's earnings history. How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health? Encompass Health announced a quarterly dividend on Wednesday, May 6th. Shareholders of record on Wednesday, July 1st will be paid a dividend of $0.28 per share on Wednesday, July 15th. This represents a $1.12 annualized dividend and a yield of 1.80%. The ex-dividend date of this dividend is Tuesday, June 30th. View Encompass Health's dividend history. What price target have analysts set for EHC? 10 analysts have issued 12 month target prices for Encompass Health's shares. Their forecasts range from $83.00 to $100.00. On average, they anticipate Encompass Health's share price to reach $91.78 in the next year. This suggests a possible upside of 47.9% from the stock's current price. View analysts' price targets for Encompass Health. Has Encompass Health been receiving favorable news coverage? News stories about EHC stock have been trending negative this week, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Encompass Health earned a daily sentiment score of -2.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about Encompass Health. Are investors shorting Encompass Health? Encompass Health saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 1,810,000 shares, a decline of 18.5% from the June 15th total of 2,220,000 shares. Based on an average daily trading volume, of 766,000 shares, the short-interest ratio is presently 2.4 days. Approximately 1.9% of the shares of the company are sold short. View Encompass Health's Current Options Chain. Who are some of Encompass Health's key competitors? Some companies that are related to Encompass Health include Ramsay Health Care Limited Fully Paid Ord. Shrs (RHC), Healthscope (HSO), Select Medical (SEM), Magellan Health (MGLN), Primary Health Care (PRY), MEDNAX (MD), Capitol Health (CAJ), Medical Facilities (DR), Animalcare Group (ANCR), SunLink Health Systems (SSY), Spine Injury Solutions (SPIN) and THC Biomed Intl (THC). View all competitors. What other stocks do shareholders of Encompass Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Adobe (ADBE), salesforce.com (CRM), Palo Alto Networks (PANW), Alibaba Group (BABA), Netflix (NFLX), Edwards Lifesciences (EW), Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX), Advanced Micro Devices (AMD) and NVIDIA (NVDA). Who are Encompass Health's key executives? Encompass Health's management team includes the following people: Mr. Mark J. Tarr, CEO, Pres & Director (Age 57)Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 57)Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 54)Ms. Barbara Ann Jacobsmeyer, Exec. VP & Pres Inpatient Hospitals (Age 53)Mr. Andrew L. Price, Sr. VP & Chief Accounting Officer (Age 52) What is Encompass Health's stock symbol? Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC." How do I buy shares of Encompass Health? Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Encompass Health's stock price today? One share of EHC stock can currently be purchased for approximately $62.06. How big of a company is Encompass Health? Encompass Health has a market capitalization of $6.17 billion and generates $4.61 billion in revenue each year. The company earns $358.70 million in net income (profit) each year or $3.91 on an earnings per share basis. Encompass Health employs 31,570 workers across the globe. What is Encompass Health's official website? The official website for Encompass Health is www.encompasshealth.com. How can I contact Encompass Health? Encompass Health's mailing address is 9001 LIBERTY PARKWAY, BIRMINGHAM AL, 35242. The company can be reached via phone at 205-967-7116 or via email at [email protected] This page was last updated on 7/8/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
